Tiny probe could give doctors a window into infant brains
NCT ID NCT06646250
First seen Apr 25, 2026 · Last updated Jun 21, 2026 · Updated 9 times
Summary
This study tests a new, lightweight ultrasound device called NeoDoppler that can be gently placed on a newborn's soft spot (fontanelle) to continuously measure blood flow in the brain. Researchers will enroll 180 preterm and full-term infants, including those with conditions like sepsis, stroke, or heart defects. The goal is to see if the device provides reliable, high-quality measurements that could help doctors monitor brain health in real time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's clinic, St. Olavs University Hospital
RECRUITINGTrondheim, 7030, Norway
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NeoDoppler device
What this could lead to
If successful, this could provide doctors with a better, non-invasive way to continuously monitor brain blood flow in fragile newborns, potentially improving care for conditions like stroke or sepsis.
What could go wrong
This is an early-stage device study focused on measurement quality, not treatment outcomes. The device may not prove reliable enough for routine clinical use, and results may not apply to all infant populations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.